The role of wild-type adenomatous polyposis coli (APC) protein in native epithelia is poorly understood. The present study examined the relationships between wildtype APC and b-catenin expression in an established model of hyperproliferation, transmissible murine colonic hyperplasia (TMCH). Distal colonic crypts isolated from normal or TMCH mice were: (i) fractionated into cytosolic and nuclear components for Western blotting and immunoprecipitation (IP), (ii) extracted for total RNA isolation for Northern blotting and, (iii) analysed immunohistochemically by confocal microscopy. Western blots performed sequentially through day 12 TMCH with N-terminal APC antibodies revealed increased abundance of B312 kDa (p312) protein by day 6 (4.070.75-fold, n ¼ 6) that peaked by day 9, before declining by day 12. A B130 kDa (p130) band appeared at day 9 and increased by day 12 (1.570.11-fold, n ¼ 6). A C-terminal antibody detected only p312. APC mRNA level did not change during TMCH and appearance of p130 was not due to alternative splicing. Co-IP with N-terminal anti-APC antibodies, revealed APC's association with b-catenin both at day 6 and day 12. p130, but not p312, associated predominantly with b-catenin at day 12 during co-IP with anti-b-catenin. p130 also selectively accumulated in the nucleus, bound to nuclear b-catenin at day 12. Immunocytochemistry with N-terminal antibodies revealed an increasing crypt base : surface gradient of APC within the apical pole/apical-lateral membranes at day 6. At day 12, intense apical/cytoplasmic and occasional nuclear staining along the longitudinal crypt axis was observed. Full-length APC increases during epithelial hyperproliferation and may represent a homoeostatic response. The dramatic increase in cytoplasmic and sporadic nuclear APC staining at day 12 with N-terminal antibodies may represent p130. The nuclear accumulation of p130 may be a novel mechanism regulating nuclear b-catenin function during TMCH.
Introduction
Molecular and functional changes in colonic epithelia precede the histologic changes observed in colon cancer. The most frequent early molecular alteration in the initiation of colon cancer involves mutations in the adenomatous polyposis coli (APC) gene, which occur both in relatively uncommon familial cancer syndromes and in B85% of sporadic cancers. The majority of these mutations result in the truncation of the APC gene product.
The human APC gene maps to chromosome region 5q21q22 and encodes for a 312-kDa (2843 amino acids) protein shown to participate in a number of cellular processes ranging from cell cycle regulation, to apoptosis, cell adhesion, cell migration, microtubule assembly, and cell fate determination (Munemitsu et al., 1994; Baeg et al., 1995; Rubinfeld et al., 1995; Morin et al., 1996; Nathke et al., 1996) . A remarkable feature of the APC protein is the presence of three 15-amino-acid repeats followed by a 20-amino-acid motif repeated seven times in its central domain. These repeats bind b-catenin, and are essential for signaling mechanisms leading to its downregulation (Rubinfeld et al., 1993; Su et al., 1993a; Munemitsu et al., 1995) . b-Catenin functions both as a cell adhesion molecule by binding to cadherins, and as a signaling molecule in the Wnt signal transduction pathway (Willert and Nusse, 1998) . In the absence of a Wnt signal, phosphorylation of b-catenin by glycogen synthase kinase-3b (GSK-3b), acting in conjunction with APC (Rubinfeld et al., 1996) , and axin/conductin (Behrens et al., 1998; Hart et al., 1998; Nakamura et al., 1998) , through a Ser-AlaMet-Pro (SAMP) motif, results in its ubiquitination and degradation.
A major function of wild-type APC is to regulate the level of free b-catenin in the cell. Integral to the hypothesis that loss of b-catenin regulation contributes to tumor progression is the demonstration that enhanced b-catenin accumulation in the cytosol and/or redistribution into the nucleus contributes to abnormal cell growth control.
Increases in proliferation have been correlated with an increased risk of colon cancer (Vogelstein et al., 1988; Fearon and Vogelstein, 1990; Vogelstein and Kinzler, 1994) . They represent an early functional change in the epithelium that precedes and accompanies malignancy. We have previously characterized an in vivo model, transmissible murine colonic hyperplasia (TMCH) to study changes in b-catenin cellular expression and signaling (Sellin et al., 2001) . TMCH is induced in mouse distal colon by Citrobacter rodentium infection (Barthold et al., , 1978 Barthold, 1979) . It is an appropriate model for a premalignant colon because there is both hyperproliferation and hyperplasia and underlying molecular changes noted in the earliest stages of neoplasia (increased abundance of b-catenin, cyclin D1, and c-myc) (Sellin et al., 2001) . Moreover, TMCH sensitizes the mucosa to neoplastic transformation, both by carcinogens and in the Min mouse Newman et al., 2001) . Since APC is recognized as the earliest and most common genetic alteration during colon carcinogenesis, we examined how increases in proliferation during TMCH correlate with cellular APC expression and distribution, in order to understand how this molecule interacts with b-catenin in a native hyperproliferating epithelium.
Results

Novel alterations in cellular levels of APC during TMCH
Infection with C. rodentium, induced a predictable and reproducible hyperproliferation/hyperplasia in adult Swiss-Webster outbred mouse distal colon at 12 days postinfection as has been shown previously (Umar et al., 2000a, b, c; Sellin et al., 2001) . We employed a battery of mono/polyclonal antibodies directed against various regions of the APC molecule (Table 1) to evaluate changes in abundance (through Western) and localization (through immunohistochemistry). Serial Western blots were performed for APC on days 0, 1, 3, 6, 9 and 12 during TMCH. Probing with Ab-1 monoclonal antibody revealed the following: (i) a B312 kDa protein (p312) corresponding to full-length APC was present at low levels in the normal colon and increased significantly by day 6 (4.070.75-fold, Po0.05, protein loading normalized to actin, n ¼ 6), peaked by day 9 before declining by day 12 (Figure 1a) , (ii) an Ab-1 immuno-reactive band at B130 kDa (p130) appeared at day 9 and increased significantly at day 12 (1.570.11-fold, Po0.05, n ¼ 6, Figure 1a ). This is the first demonstration of an increased abundance of full-length APC and appearance of a p130 protein in hyperproliferating native epithelia. This suggests that APC protein expression plays a physiological role in the cellular hyperproliferatory response of the normal epithelium.
To characterize p130 further, we probed the blots with N-and C-terminal mono and polyclonal antibodies (F-3 and C-20, Table 1 ), respectively. C-20 detected p312 both at day 6 (3.070.65-fold, Po0.05, n ¼ 6) and to a lesser extent at day 12 while p130 was not detectable at these time points (Figure 1b) , suggesting that p130 may be a part of p312 N-terminal domain.
Indeed, probing with an N-terminal antibody, F-3, detected predominantly p312 at day 6 and p130 at day 12 TMCH (Figure 2 ). Probing the same blot with C-20 again failed to detect a p130 band (Figure 2) . Thus, appearance of p130 is associated with changes in the proliferatory status of the colonic epithelium.
Nuclear translocation of APC proteins during TMCH
Since full-length APC protein has been reported to undergo nuclear translocation in cancer cell lines and in tumors (Wong et al., 1996; Neufeld and White, 1997; Efstathiou et al., 1998; Deka et al., 1999) , we isolated purified nuclei to determine presence or absence of APC proteins in native epithelia. Nuclear p312 was not detectable either at day 6 or at day 12 with either Ab-1 (Figure 3 ) or F-3 (data not shown) antibodies, respectively. p130, however, selectively accumulated in the nucleus at day 12 (3.570.8-fold, relative to lamin B) (Figure 3 , n ¼ 6).
The purity of nuclear preparation was confirmed by the presence of lamin B (Figure 3 , n ¼ 6). p130 nuclear accumulation suggests that it may not be a simple degradation product of p312, but may represent a novel, Full-length APC protein (p312) levels increased significantly by day 6. The 130 kDa fragment (p130) appeared at day 9 and increased in abundance at day 12 TMCH. C-20 antibody failed to detect p130 (n ¼ 6) biologically relevant pathway for regulating b-catenin function in nontransformed epithelia.
APC message did not change during TMCH
To determine whether (i) changes in APC mRNA levels contribute towards increased protein abundance during TMCH, and (ii) to see whether p130 is a result of alternative splicing, Northern blot analysis of total cellular RNA was performed in sequentially isolated crypt samples. Relative abundance of APC mRNA did not change during TMCH (Figure 4 ). We observed two APC bands of approximately 9 kb (major) and 10 kb (weaker), respectively. These bands are probably attributable to alternative splicing similar to previous reports (Horii et al., 1993; Oshima et al., 1993; Thliveris et al., 1994; Santoro and Groden, 1997) . However, we did not observe presence of an alternatively spliced variant of APC small enough to code for p130 suggesting that generation of p130 may be a post-translational event.
Association of APC proteins with b-catenin during crypt hyperproliferation Co-immunoprecipitation (co-IP) studies were performed to determine the relationship between APC proteins and b-catenin in native epithelia. Initially, IPs were carried out with Ab-5 APC antibody in day 12 crypt extracts followed by Western blotting with Ab-1 (see Materials and methods, and Table 1 ). Both p312 and p130 proteins were immuno-precipitated by Ab-5 and detected by Ab-1 (Figure 5a ).
Subsequently, IP was performed with Ab-5 either at day 6, when p312 expression increased (fourfold), or at day 12, when p312 expression began to decline with the appearance of p130. Immunoprecipitated proteins were then subjected to Western blotting with anti b-catenin antibody. b-Catenin associated with APC both at day 6 and at day 12 with equal measure (Figure 5b ).
The persistence of b-catenin immunoreactivity at day 12 when p312 expression decreases (Figure 1) , suggested that alongwith p312, b-catenin may also be interacting with p130. Indeed, IP first with anti-b-catenin antibody followed by blotting with Ab-1 exhibited bulk of p130's association with b-catenin at day 12 (Figure 5c ). These findings suggest that p130 retains a b-catenin binding motif. (D 12 ) TMCH crypts were analysed by Western blotting with Ab-1. p312 nuclear translocation was not detected during TMCH. p130 selectively accumulated in day 12 TMCH crypts. Protein loading was normalized to lamin B Figure 4 Mucosal hyperplasia does not affect APC mRNA abundance. Total RNA was extracted from colonic crypts isolated from normal (N) and 1-15 days postinfected mouse distal colon. Total RNA (10 mg each) was separated on a denaturing gel and blotted. The membranes were probed for APC (top) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH, bottom), respectively. The positions of the 18S and 28S ribosomal RNAs, as detected with ethidium bromide, are indicated. Relative abundance of APC mRNA did not change during TMCH Since GSK-3b also forms complexes with APC, we reprobed the APC Ab-5 immunoblots with anti GSK-3b antibody. While an association of GSK-3b with p312 APC was detected at day 6, GSK-3b did not associate with APC at day 12 ( Figure 5d ). These findings suggest that Ab-5 is predominantly binding p130 at day 12 and that p130 does not contain GSK-3b binding activity, that is, p130 does not contain SAMP binding sites.
To determine whether nuclear p130 interacts with nuclear translocated b-catenin, IP was carried out with Ab-5 in both day 6 and day 12 nuclear extracts followed by Western blot with both Ab-1 and anti b-catenin antibodies (Table 1) , respectively. At day 6, no nuclear p130 immuno-reactivity could be detected with Ab-1 while at day 12, strong nuclear immuno-reactivity was observed for p130 ( Figure 6Ai ). When the same blot was reprobed with anti b-catenin antibody, p130 associated predominantly with b-catenin at day 12 ( Figure 6Aii ). The minimal association of b-catenin with p130 at day 6 was not due to absence of b-catenin in the nucleus since strong immunoreactivity for b-catenin was detected both at days 6 and 12 TMCH with antibody specific for nuclear b-catenin (Figure 6Aiii ). Thus, p130 specifically accumulated in the nucleus at day 12 TMCH, as was observed above (see Figure 3 ), and interacted with nuclear b-catenin. This was further confirmed by IP with anti-b-catenin followed by immunoblotting with Ab-1. p130 predominantly associated with nuclear b-catenin at day 12 TMCH ( Figure 6B ).
Immunofluorescence staining of APC
We next examined the immuno-localization of APC in isolated crypts to understand whether increased cellular expression and nuclear translocation during TMCH were paralleled by changes in either its subcellular distribution or localization along the crypt-surface axis. We employed both (i) antibodies used in Western blots and (ii) several additional antibodies (Table 1) to assess the consistency of signal localization along the crypt and intracellularly keeping in mind the recent observations raising concerns about the specificity of commercially available antibodies (Brocardo et al., 2005) .
In normal colonic crypts, cells at the base exhibited weak punctate staining with Ab-7 antibody (Figure 7a , arrow). At day 6, a gradient of increasing crypt base : surface APC immunoreactivity was seen along the cellular subapical pole (Figure 7a , arrow). These results correlated with fourfold increase in p312 protein abundance at day 6 (Figure 1 ). At day 12 TMCH, intense subapical pole immunoreactivity extending throughout the longitudinal cellular axis of the crypt was observed (Figure 7a , open arrow) while Ab-7 failed to detect nuclear staining either at day 6 or at day 12 TMCH, respectively.
Concurrently processed crypts in which the primary antibody had been replaced with purified mouse IgG, failed to exhibit staining ( Figure 7b ). All crypts were processed and imaged identically, with no alteration in postimage-capture signal gain.
For staining specificities, we utilized two N-terminal (F-3 and Ob, Table 1 ) mono-and polyclonal antibodies, , open arrow) immunoreactivity extending throughout the longitudinal cellular axis of the crypt was observed with Ob antibody while nuclear immunoreactivity could occasionally be seen at this optical resolution. Concurrently processed crypts in which the primary antibody had been replaced with purified mouse IgG, failed to exhibit staining ( Figure 8b ). Figure 9A is a representative example of APC immunostaining with an N-terminal (residues 2-289) monoclonal antibody (F-3) in a 0.45 mm (midcrypt) z-axis fluorescent light section obtained from normal distal colonic crypt. APC immunoreactivity was confined to apical subcellular pole within the lower (basal) regions of the longitudinal crypt axis (Figure 9Aai ). This was further confirmed by a cross-sectional reconstruction of 100 individual x-z (80 mm Â 0.5 mm) axial planes (Figure 9Aii , arrow). At day 6 TMCH, intense apical punctate staining was recorded throughout the longitudinal crypt axis (Figure 9Bia ), similar to that recorded with Ab-7. Mid-crypt z-axis planes from day 6 crypts clearly demonstrated the extended apical labeling across the x-y planes (Figure 9Bii ). Volumetric reconstruction of x-z axial planes exhibited predominantly apical labeling both at the base and at the midcrypt regions (Figure 9Bii , arrows) with very little cytoplasmic staining. No nuclear immunoreactivity was detected.
At day 12 TMCH, intense apical pole punctate staining similar to Ab-7 was detected at the base of the crypt (Figure 9Cia) . However, the staining became more diffuse towards the surface suggesting cytoplasmic immunoreactivity. Mid-crypt z-axis planes clearly demonstrated diffuse staining along the x-y planes ( Figure  9Cii , arrow). Volumetric reconstruction of x-z axial planes exhibited apical labeling at the crypt base ( Figure  9Cii , arrow) but more cytoplasmic staining towards the mid-crypt to surface regions (Figure 9Cii, arrow) . These findings correlated with staining pattern observed with Ob (see Figure 8) , suggesting that same epitopes are being recognized by two different antibodies.
A more detailed analysis of x-z axial planes of a similarly processed D12 crypt clearly established apical to cytoplasmic staining pattern with F-3 antibody. Figure 10a represents a single 0.45 mm mid-crypt z-axis plane of cellular APC immunoreactive apical pole and cytoplasmic/nuclear labeling. Reconstruction of x-z axial planes revealed more detail to the cellular and subcellular APC staining profile. As observed earlier, apical punctate staining was recorded at the base of the crypt (Figure 10ci ), without any nuclear staining (arrow). These staining patterns became more cytoplasmic and occasionally nuclear towards the crypt surface (regions ii-iv, Figure 10c, arrow) .
Thus, increased APC abundance noted on Western blots is due to both increased concentration of APC, that is, increased expression/cell, and increased distribution, that is, increased number of cells/crypt expressing elevated APC at both days 6 and 12 TMCH.
Thus, we observed increased intensities corresponding to p312 and p130 proteins with both Ab-7 and F-3 monoclonal antibodies, respectively. Significant increases in cytoplasmic alongwith occasional nuclear APC staining observed at day 12 with both F-3 and Ob N-terminal antibodies may represent specific intracellular localization of p130 rather than p312 that correlate with Western blots. Table 1 ). At day 6, a gradient of immunoreactivity along the apical membrane was present (arrow) alongwith apical lateral staining towards the surface (arrowhead). At day 12, enhanced cellular apical staining was observed throughout the crypt axis (open arrow) with Ab-7. (b) Matched controls with control IgGs failed to show any signal ( Â 400 magnification; results represent between six and eight individual crypt observations repeated in 12 animals) Figure 8 Polyclonal antibody recognizes both p312 and p130 and exhibits distinct immunofluorescent labeling: (a) Normal crypts exhibited weak staining with Ob antibody (see Table 1 ). At day 6, an increasing crypt base : surface gradient of APC along the apical membrane (arrow) alongwith cytoplasmic and lateral staining towards the surface. At day 12, intense labeling throughout the crypt axis alongwith significant increases in cytoplasmic (arrow) and occasional nuclear labeling could be seen indicating presence of p130 ( Â 400 magnification; results represent between six and eight individual crypt observations repeated in 12 animals). (b) Matched controls with control IgGs, failed to show any signal
Discussion
Despite the extensive focus on mutated APC in colon cancer and in cell lines, our understanding of the physiologic role(s) of wild-type APC are still limited. We found that during transmissible murine colonic hyperplasia, (a) the expression of full-length APC (p312) increased fourfold by day 6 post-Citrobacter infection. However, significant decreases followed at day 12 TMCH, corresponding to the time of peak cellular hyperproliferation/hyperplasia; (b) N-terminal antibodies (Ab-1, F-3) also detected a smaller APC protein (p130) at day 9, which markedly increased by day 12. Probing with C-20 detected only p312 at these times; (c) APC mRNA abundance did not increase during TMCH and appearance of p130 was not due to alternative splicing of Apc; (d) IP with Ab-5 and blotting with antib-catenin, revealed b-catenin's association with both p312 (at day 6) and p312 þ p130 (at day 12) proteins. However, IP with anti-b-catenin followed by blotting with Ab-1 revealed bulk of p130's association with b-catenin at day 12; (e) selective nuclear accumulation of p130 bound to b-catenin; (f) corresponding increases in APC abundance and distribution along the crypt axis during proliferation detected immunohistochemically, and (g) different distribution pattern corresponding to p312 (at day 6) and predominantly p130 (at day 12) proteins.
The APC protein is expressed at low levels in the normal epithelial cell. The present study demonstrates for the first time, increased abundance of full-length APC protein during hyperproliferation of the normal colonic mucosa (see Figure 1 ). This increase in APC protein abundance could not be attributed to increases in APC transcription as Northern blotting failed to exhibit relative changes in APC mRNA (see Figure 4) suggesting that other relevant post-transcriptional/ Figure 9 Confocal laser scanning microscope (CLSM) images made at high spatial resolution ( Â 400) in distal colonic crypts isolated from normal, day 6 and day 12 TMCH. Crypts from these time points were simultaneously fixed, permeabilized, incubated with F-3 and processed for immunofluorescence. (A) Normal crypts exhibited weak apical punctate staining at their base (ia) shown more clearly in the corresponding orthogonal x-z plane (ii, arrow). (B) Day 6 crypts exhibited intense apical punctate staining throughout the longitudinal crypt axis (ia and ii, arrow) with lateral staining towards the surface. (C) At day 12 TMCH, intense apical staining at the base with increasing cytoplasmic staining towards the surface, could be seen (ia and ii, arrow). All b lanes represent bright field images. Images shown here were collected using same image capture gains and were not differentially enhanced Figure 10 CLSM high spatial resolution of an isolated crypt from day 12 TMCH demonstrating F3 staining. F3 immunoreactive (a) and bright field (b) signals from a single 0.45 mm mid-crypt z-axis fluorescence light plane depicting detailed cellular and subcellular immunoreactivity. At this resolution, apical punctate staining was recorded at the base of the crypt (ci) without any nuclear staining (arrow). Staining became more cytoplasmic and nuclear towards the surface (regions cii-civ, arrow) translational mechanisms may be responsible for increased protein abundance during TMCH. Previously, we reported significant increases in b-catenin abundance by day 1 of TMCH with progressive increase for the next several days (Sellin et al., 2001) . Thus, increased cellular b-catenin during TMCH is not due to decreased APC abundance. The increase in APC is a novel finding: we hypothesize that this may represent a homoeostatic effort by the epithelium to respond to the increases in b-catenin abundance during TMCH.
We also demonstrate appearance of a 130 kDa protein that we suggest may be a fragment of APC (see Figure 1 ), which accumulates in the nucleus at peak hyperplasia (see Figure 3) . Again, the identification of APC fragment in the native hyperproliferating epithelium is a novel observation; it may represent a biologically relevant and specific mechanism for regulating APC activity and subsequent b-catenin function in vivo. During Northern analysis, we did not find any evidence to support the notion that p130 could be an alternatively spliced variant of p312 (see Figure 4) . Both truncation products and isoforms of APC have been identified in various epithelial backgrounds, either by immunohistochemistry or by Western blotting. These low molecular weight products of APC (B90-140 kDa) do not contain the functional domains of APC protein responsible for interaction with several of its binding partners. However, majority of them retain a highly conserved amino-terminal third armadillo repeat domain and the 15-amino-acid repeat motif for constitutive b-catenin binding.
Here, we show that both p312 and p130 APC proteins associate with b-catenin (see Figure 5 ). Given APC's recognized role in b-catenin degradation, the association of full-length APC with b-catenin at day 6 may represent a cellular response to an increased abundance of b-catenin and promotion of degradation. Interestingly however, b-catenin was not degraded as a result of this association. This may be due to inactivation of GSK-3b during TMCH preventing phosphorylation of b-catenin at specific residues required for b-transducing repeat containing protein (b ÀTRCP ) binding that leads to destruction of b-catenin (manuscript in preparation).
The role of p130 in regulating b-catenin abundance has not been defined, that is, whether it promotes a b-catenin degradation pathway or alternatively, sequesters b-catenin to prevent its degradation. Thus, at day 12 TMCH, with increased p130 and minimal p312 expression, the effect of APC on cellular regulation of b-catenin function is not known. Clearly, one would expect that these deviations from full-length APC can alter cellular distribution, binding partners, and paripassu, function. Indeed, it has been shown recently that three N-terminal 15-amino-acid repeat regions in APC (APC3 Â 15) play a positive role in the control of transcriptional activity of b-catenin/Tcf-4 and can contribute to explain the role of the truncated forms of APC in colon carcinogenesis (Roura et al., 2003) . In defining the effect of APC, it will be important therefore to delineate different APCs and their varying biological roles.
The potential importance of APC fragments has also been brought to the fore recently as caspase-like proteolytic cleavage products of APC have been demonstrated in cancer cells of the hemopoietic and epithelial lineages, respectively (Browne et al., 1998; Webb et al., 1999) . Proteolysis results in generation of a large apparently stable amino-terminal fragment (B90 kDa). However, these fragments have been reported to appear only in cells undergoing apoptosis in vitro (Browne et al., 1998; Webb et al., 1999) . p130 accumulated throughout the crypt, and did not localize to zones of expected apoptosis. Appearance of p130 may therefore, represent a novel pathway to regulate wild-type APC expression during hyperproliferation of the native epithelia.
Increased cytoplasmic expression of APC proteins is associated with alterations in immunocytochemical distribution
In the present study, basal cells of the normal crypt exhibited weak punctate APC staining. At day 6, a gradient of increasing crypt base : surface APC immunoreactivity along the apical membrane was observed with apical-lateral staining towards the surface. The staining intensity correlated with fourfold increase in p312 protein abundance. At day 12, intense labeling extending throughout the longitudinal cellular axis of the crypt alongwith cytoplasmic staining was observed.
Immunohistochemical analysis of transformed cells in culture has shown that APC antigenicity is present in both the cytoplasm and nucleus (Neufeld and White, 1997) . In intact tissues as well, several investigators find cytoplasmic and/or nuclear APC (Wong et al., 1996; White, 1997; Iwamoto et al., 2000) , while others have found it primarily in the apical membrane Reinacher-Schick and Gumbiner, 2001) . Apical membrane-bound APC, however, does not seem to participate in b-catenin degradation. There have been variable reports on staining of goblet and Paneth cells (Iwamoto et al., 2000) . Utilizing multiple antibodies (see Table 1 ), we demonstrate considerable subapical staining related to p312 (at day 6) and predominantly p130 (at day 12) APC proteins during TMCH. Truncated mutants of APC may exhibit apical membrane localization in vitro (McCartney and Peifer, 2000) indicating that loss of its tumor suppressor function is not attributable to alterations in its localization. Although the precise motif required for apical membrane insertion is not known, an intact armadillo repeat region, usually retained by truncated APC, may be sufficient.
Nuclear role for p130
Full-length APC protein can localize to the nucleus of transformed cell lines and tumors (Wong et al., 1996; Neufeld and White, 1997; Efstathiou et al., 1998; Deka et al., 1999) . However, most, if not all, studies in native epithelia do not show consistent nuclear signal either by immunohistochemistry, or by Western blotting. At day 6 TMCH, we did not find nuclear accumulated p312 (see Figure 3) , even though the cellular abundance increased fourfold, compared to normal crypt (see Figure 1) . At day 12 TMCH, nuclear accumulation of p130 but not p312, was observed both biochemically (see Figure 3) and by immunofluorescent labeling (see Figure 9) . Two putative nuclear localization signals (NLSs) at C-terminal amino acids 1767-1772 and 2048-2053, which are well conserved among human, rat, mouse and fly, have been implicated for optimal nuclear import (Neufeld and White, 1997) . Moreover, phosphorylation near these NLSs regulates nuclear import of APC in cell lines (Zhang et al., 2000) . During TMCH therefore, mechanisms regulating post-translational modification of APC in vivo may be deregulated thereby affecting phosphorylation and subsequent nuclear import of p312. However, since p130 is not expected to have these NLSs, the fact that p130 still accumulates in the nucleus at day 12 TMCH, is indeed intriguing.
It is likely that additional nuclear import mechanisms, including recently described N-terminal armadillo domain-dependent nuclear import, exist for truncated APC proteins. Indeed, mutant APC proteins lacking both the known NLSs have been demonstrated in the nucleus of cancer cells (Smits et al., 1999; Henderson, 2000; Galea et al., 2001 ). More recently, it has been predicted that truncated proteins lacking the C-terminal domains may not be sequestered by microtubules as efficiently as full-length APC, and therefore may enter the nucleus more efficiently (Brocardo et al., 2005) . However, the mechanisms responsible for nuclear accumulation of p130 remain to be determined.
To assign a biological role for p130, we determined its association with nuclear b-catenin during TMCH. Since negligible p130 is present at day 6 TMCH, no association of p130 with b-catenin was recorded (see Figure 6 ). At day 12 TMCH, however, we observed a strong association of p130 with b-catenin ( Figure 6 ). Recent studies have shown that APC may shuttle b-catenin between the nucleus and the cytoplasm by utilizing highly conserved nuclear export signals (NESs) within the APC protein (Henderson, 2000; Neufeld et al., 2000a; Rosin-Arbesfeld et al., 2000; Zhang et al., 2000) . However, the functional role of APC in the nucleus is still less clear and previously reported observations are somewhat contradicting. For example, nuclear APC has been found to sequester b-catenin and promote its nuclear export (Henderson, 2000; Neufeld et al., 2000b; Rosin-Arbesfeld et al., 2000) . On the other hand, b-catenin translocation between cytoplasm and nucleus can occur independently of APC (Fagotto et al., 1998; Eleftheriou et al., 2001; Wiechens and Fagotto, 2001) . In MDCK cells, the nucleocytoplasmic distribution of APC was recently found to vary depending on cell density (Zhang et al., 2001) ; nuclear accumulation of APC was seen in subconfluent cells, whereas superconfluent cultures, presumed to have entered G0, showed no such accumulation. However, a recent report (Brocardo et al., 2005) has shown that fluctuation in cell density does not regulate nuclear localization of APC and that both wild-type and truncated APCs are predominantly cytoplasmic. These are all in vitro studies. The correlations between findings in vivo and in vitro have not been established but clearly have significant importance on assessing the physiological role(s) of APC.
We have shown recently that b-catenin is integral to hyperproliferation/hyperplasia observed during TMCH (Sellin et al., 2001; Umar et al., 2003) . We speculate that hyperproliferating colonic epithelium may promote nuclear accumulation of p130 independently of b-catenin cotranslocation. Indeed, alongwith Figure 6 , we now have observed nuclear accumulation of b-catenin as early as day 3 postinfection (manuscript in preparation) while p130 cellular levels did not increase significantly until 12 days postinfection. Interestingly, p130's interaction with nuclear b-catenin did not apparently abrogate hyperplasia, suggesting that sequences critical for transcriptional coactivation are not blocked by p130 interaction. Infact, APC3x15 fragment has been shown to increase the transcriptional activity of the b-catenin-TCF-4 complex even though both TCF-4 and APC3x15 fragments bind overlapping regions of b-catenin (Spink et al., 2001; Roura et al., 2003) . At the same time, a nuclear-cytoplasmic shuttling role for p130 cannot be ruled out, given its presence in both the cytoplasm and nucleus.
p130's interaction with nuclear b-catenin could be a novel pathway to modulate nuclear b-catenin-stimulated cell proliferation in native epithelia. Moreover, in vivo existence and stability of a fragment of APC (p130) may represent a crucial determinant for a dominant-negative mechanism leading to functional loss of tumor suppression of the APC gene product. Indeed, partial or complete loss of APC function may lead to dramatic increases in nuclear accumulation of b-catenin and a 'crypt progenitor-like' phenotype (Sansom et al., 2004) . Thus, while mutational inactivation or epigenetic silencing of Apc gene via promoter methylation may not seem critical during TMCH, APC/b-catenin pathway may be deranged because of alterations of other binding partners involved in this signaling cascade (e.g., GSK-3b, manuscript in preparation). These changes may lock APC in a signaling mode and may be important in maintaining a crypt progenitor-like phenotype during TMCH by providing survival advantage to hyperproliferating colonocytes. The TMCH model therefore provides an excellent opportunity to understand how altered crypt dynamics affects various APC functions critical to mucosal priming for subsequent neoplasia.
Materials and methods
Transmissible murine colonic hyperplasia
As described previously (Umar et al., 2000a, b, c; Sellin et al., 2001) , Swiss-Webster mice were given an overnight culture of C. rodentium mixed with drinking water. At 12 days postinfection, animals were euthanized, and the distal colon was removed. The characteristic findings of TMCH were invariably present: a grossly thickened distal colon, with no other changes noted in the remainder of the colon or within the peritoneal cavity. Microscopically, crypt length increased significantly with no obvious increase in epithelial or submucosal inflammatory cell numbers. Our prior studies have demonstrated an eightfold increase in proliferation as measured by bromodeoxyuridine labeling (Umar et al., 2000a) .
Isolation of crypts and subcellular fractionation
Distal colonic crypts from normal and C. rodentium-infected mice were isolated and purified as described previously (Umar et al., 2000a, b, c) . Crude cellular homogenates were prepared by homogenization in buffer (50 mM Tris-HCl, 250 mM sucrose, 2 mM EDTA, 1 mM EGTA (pH 7.5), 10 mM 2-mercaptoethanol, 0.5% Triton X-100, plus protease inhibitors). After centrifugation (15 000 g for 15 min), the clear supernatant was saved as total solubilized protein cell extract. Nuclear extracts were prepared from freshly isolated crypts essentially as described previously (Umar et al., 2000c) . Protein concentrations were determined, and extracts were frozen in liquid nitrogen and stored at À701C.
IP and Western blotting
For IP studies, crypt cytosolic or nuclear extracts were normalized for protein concentration and precleared for 1 h at 41C with 30 ml of protein A-coated Sepharose beads. IP was carried out at 41C by incubating the fractions for 2 h with an N-terminal anti-APC antibody Ab-5 (see Table 1 regarding selection of antibodies), or anti b-catenin antibody and then for 1 h with 50 ml of protein A/G-Sepharose beads. Control experiments were performed by carrying out the IPs in the presence of the immunizing peptides, or with control IgG antisera. The IPs proteins were recovered by boiling the Sepharose beads in 2 Â SDS sample buffer.
Total crypt extracts, subcellular fractions (30-100 mg protein/lane) or immunoprecipitated proteins were subjected to SDS-PAGE and transferred to nitrocellulose/PVDF membrane. The transfer efficiency was checked by back staining gels with Coomassie Blue and/or by reversible staining of the electrotransferred protein on the membrane with Ponceau S solution. No variability in transfer was noted. Destained membranes were blocked with 5% nonfat dried milk in TBS (20 mM Tris-HCl and 137 mM NaCl (pH 7.5)) for 1 h at room temperature and processed for Western blots with appropriate antibodies (Table 1 , 0.5-1.0 mg/ml in TBS containing 0.1% Tween 20 (TBS/Tween); Sigma, St Louis, MO, USA) and ECL detection system (Amersham, Arlington Heights, IL, USA). Protein loading was normalized by blotting with anti-actin antibody (ICN Biochemicals, Aurora, OH, USA).
Northern blot analysis and RT-PCR
Total cellular RNA was extracted from purified crypts isolated from normal and Citrobacter-infected distal colon using TRIzol reagent (GIBCO BRL, Grand Island, NY, USA) according to the manufacturers' instructions. For Northern blot analysis, total RNA (10 mg each) was fractionated through formaldehyde-containing agarose gels, transferred onto HybondtN þ nitrocellulose membrane (Amersham Biosciences) and crosslinked with UV Stratalinker 1800 (Stratagene, La Jolla, CA, USA). Probes were generated using the Rediprime II random prime labeling system (Amersham Biosciences) supplemented with [a-32 P]dCTP. Hybridizations with 32 P-labeled APC or GAPDH probes were carried out at 681C in PerfectHyb TM Plus hybridization buffer (SigmaAldrich, St Louis, MO, USA). The latter signal was used to normalize the mRNA in each lane. The probe for APC detection was generated by PCR of cloned full-length APC cDNA (a gift from Dr Joanna Groden, University of Cincinnati) using following primers: forward 5 0 -GAAGTCAG TCGGCATCTAAAGGA-3 0 and reverse 5 0 -TCTCCAAGTA CTCACTCGAGG-3 0 . The probe for GAPDH was generated by RT-PCR from mouse colonic RNA (Umar et al., 2000a) . Both were confirmed by oligonucleotide sequencing before random primed labeling.
Immunocytochemistry and confocal microscopy
Freshly isolated or preserved crypts were processed for immunohistochemistry as described previously (Sellin et al., 2001) , utilizing Ab-7, F-3 and Ob antibodies, respectively (Table 1 ). For immunodetection, the specimens were incubated at room temperature with either FITC-conjugated goat anti-mouse (Santa Cruz Biotechnology, Santa Cruz, CA, USA; 1 : 100) or Cy2-conjugated goat-anti rabbit (Jackson Laboratories, West Grove, PA, USA) secondary antibodies, respectively. Antibody controls included omission of the primary antibody, and detection of endogenous IgG with goat anti-mouse/anti-rabbit IgGs (Calbiochem, San Diego, CA, USA).
Crypts were viewed using a Nikon Diaphot inverted microscope equipped with Nikon Fluor Â 20 and Â 40 objective lenses as described previously (Sellin et al., 2001; Umar et al., 2000a, c) . Specimen scanning was achieved by an Odyssey Real Time Laser Confocal System (Noran Instruments, Inc., Middleton, WI, USA). The fluorescent secondary antibodies were excited with the 488 nm line of an argon gas laser and emitted light detected after band pass at þ 515 nm before being digitally reconstructed into (512 Â 512) 8-or 24-bit maps. Final image magnifications ranged between Â 200 and Â 1200, depending on the numerical aperture of the objective lens. The resulting images were stored and analysed on an IBM-PC loaded with Image-1 Metamorph Imaging Software (Universal Imaging Corp.).
Abbreviations APC, adenomatous polyposis coli; FITC, fluorescein isothiocyanate; PAGE, polyacrylamide gel electrophoresis; TBS, tris buffered saline; TMCH, transmissible murine colonic hyperplasia.
